Population
Vascular smooth muscle cell line expressing the angiotensin II AT2 receptor and control cells
Comparison
Angiotensin II treatment in the presence of a… vs Control cells treated with Angiotensin II, or…
Design
Preclinical
Authors
Loading...
AT2R activation may limit SMC migration in vascular disease; extends mechanistic data but leaves open in vivo relevance and clinical translation.
Activation of the angiotensin II AT2 receptor inhibits vascular smooth muscle cell migration by increasing cellular fibronectin synthesis and binding.
Chassagne et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: